Published in World J Surg on June 01, 2010
A Trial Comparing USG-HIFU vs AS in Management of Low-risk PTMC | NCT03327636
Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid (2013) 2.66
Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons. World J Surg (2011) 1.49
Risk stratification of thyroid nodules on ultrasonography with the French TI-RADS: description and reflections. Ultrasonography (2015) 1.29
Incidences of Unfavorable Events in the Management of Low-Risk Papillary Microcarcinoma of the Thyroid by Active Surveillance Versus Immediate Surgery. Thyroid (2015) 1.16
A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma. Thyroid (2015) 1.10
Radioactive iodine therapy decreases recurrence in thyroid papillary microcarcinoma. ISRN Endocrinol (2012) 0.97
The changing incidence of thyroid cancer. Nat Rev Endocrinol (2016) 0.96
Natural History of Asymptomatic Papillary Thyroid Microcarcinoma: Time-Dependent Changes in Calcification and Vascularity During Active Surveillance. World J Surg (2016) 0.96
Thyroid nodules. Med Clin North Am (2012) 0.94
Nonoperative management of low-risk differentiated thyroid carcinoma. Curr Opin Oncol (2015) 0.92
How Many Contralateral Carcinomas in Patients with Unilateral Papillary Thyroid Microcarcinoma are Preoperatively Misdiagnosed as Benign? World J Surg (2017) 0.92
Clinical Trials of Active Surveillance of Papillary Microcarcinoma of the Thyroid. World J Surg (2016) 0.91
Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph-node metastases: a population-level analysis. Thyroid (2013) 0.87
Ultrasound-guided laser ablation of incidental papillary thyroid microcarcinoma: a potential therapeutic approach in patients at surgical risk. Thyroid (2011) 0.87
Association between serum thyrotropin concentration and growth of asymptomatic papillary thyroid microcarcinoma. World J Surg (2014) 0.87
Thyroid incidentalomas: epidemiology, risk stratification with ultrasound and workup. Eur Thyroid J (2014) 0.86
Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma. BMC Cancer (2012) 0.86
Prognostic factors of papillary and follicular carcinomas in Japan based on data of kuma hospital. J Thyroid Res (2011) 0.84
Detection of Tumor Multifocality Is Important for Prediction of Tumor Recurrence in Papillary Thyroid Microcarcinoma: A Retrospective Study and Meta-Analysis. J Pathol Transl Med (2016) 0.84
The Revised 2016 Korean Thyroid Association Guidelines for Thyroid Nodules and Cancers: Differences from the 2015 American Thyroid Association Guidelines. Endocrinol Metab (Seoul) (2016) 0.82
Revisiting Low-Risk Thyroid Papillary Microcarcinomas Resected Without Observation: Was Immediate Surgery Necessary? World J Surg (2016) 0.81
E-cadherin expression and cell proliferation in the primary tumor and metastatic lymph nodes of papillary thyroid microcarcinoma. Mol Clin Oncol (2013) 0.79
Ultrasound texture analysis: Association with lymph node metastasis of papillary thyroid microcarcinoma. PLoS One (2017) 0.78
Thyroid Papillary Microcarcinoma: Etiology, Clinical Manifestations,Diagnosis, Follow-up, Histopathology and Prognosis. Iran J Pathol (2016) 0.78
BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study. Mod Pathol (2015) 0.78
Incidental thyroid carcinoma by FDG-PET/CT: a study of clinicopathological characteristics. Ann Surg Oncol (2010) 0.78
Diagnostic value of two-dimensional shear wave elastography in papillary thyroid microcarcinoma. Onco Targets Ther (2016) 0.77
Solitary lateral neck node metastasis in papillary thyroid carcinoma. World J Surg Oncol (2014) 0.77
What is the Minimal Surgery for Papillary Thyroid Carcinoma? Rambam Maimonides Med J (2016) 0.76
The Effectiveness of Radioactive Iodine Remnant Ablation for Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-analysis. World J Surg (2016) 0.76
Effects of Pregnancy on Papillary Microcarcinomas of the Thyroid Re-Evaluated in the Entire Patient Series at Kuma Hospital. Thyroid (2015) 0.75
The impact of presence of Hashimoto's thyroiditis on diagnostic accuracy of ultrasound-guided fine-needle aspiration biopsy in subcentimeter thyroid nodules: A retrospective study from FUSCC. Cancer Med (2017) 0.75
The surgical approach to managing differentiated thyroid cancer. Indian J Med Res (2016) 0.75
Restricting ultrasound thyroid fine needle aspiration biopsy by nodule size: which tumors are we missing? A population-based study. Endocrine (2015) 0.75
Incidental and non-incidental thyroid microcarcinoma. Oncol Lett (2016) 0.75
Therapeutic Strategies and Clinical Outcome in Papillary Thyroid Microcarcinoma: A Multicenter Observational Study. Eur Thyroid J (2016) 0.75
Thyroid nodules and cancer management guidelines: comparisons and controversies. Endocr Relat Cancer (2016) 0.75
RE: Management of Low-Risk Papillary Thyroid Microcarcinoma. Korean J Radiol (2017) 0.75
A rose by any name surely does smell just as sweetly: The controversy over revised nomenclature for encapsulated follicular variant papillary carcinoma. J Transl Int Med (2016) 0.75
The Genetics of Papillary Microcarcinomas of the Thyroid: Diagnostic and Prognostic Implications. Curr Genomics (2017) 0.75
Controversies in the Management of Low-Risk Differentiated Thyroid Cancer. Endocr Rev (2017) 0.75
Surgeon-performed intraoperative tumor localization in recurrent papillary thyroid carcinoma by ultrasound-guided intratumoral indigo carmine injection. World J Surg (2014) 0.75
A new paradigm in low-risk papillary microcarcinoma: active surveillance. Endocrinol Diabetes Metab Case Rep (2017) 0.75
Clinical features of recently diagnosed papillary thyroid carcinoma in elderly patients aged 65 and older based on 10 years of sonographic experience at a single institution in Korea. Ultrasonography (2017) 0.75
Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA (2006) 22.71
Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid (2006) 12.23
Medical professionalism in the new millennium: a physicians' charter. Lancet (2002) 5.93
American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract (2006) 4.62
An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery (1988) 3.27
An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid (2003) 3.23
Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg (2003) 2.80
A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery (2004) 2.73
Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality. Cancer (2003) 2.58
Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery (1987) 2.42
Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J Clin Endocrinol Metab (2006) 2.31
Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery (2008) 2.23
AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology. Endocr Pract (2001) 2.15
Papillary microcarcinoma. World J Surg (2008) 1.96
Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): a mono-institutional experience. J Surg Oncol (2007) 1.77
Geographic pathology of occult thyroid carcinomas. Cancer (1975) 1.71
Thyroid papillary microcarcinoma: a descriptive and meta-analysis study. Eur J Endocrinol (2008) 1.65
Management of low-risk differentiated thyroid cancer. Endocr Pract (2007) 1.39
A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid. Nat Clin Pract Endocrinol Metab (2007) 1.35
Analysis of differential BRAF(V600E) mutational status in high aggressive papillary thyroid microcarcinoma. Ann Surg Oncol (2008) 1.34
Papillary microcarcinoma of the thyroid: how should it be treated? World J Surg (2004) 1.26
Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients. Eur J Surg Oncol (2006) 1.26
Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid. World J Surg (2004) 1.24
Occult thyroid carcinoma at autopsy in Malmö, Sweden. Cancer (1981) 1.10
Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control. Surgery (2007) 1.09
Occult thyroid carcinoma in Olmsted County, Minnesota: prevalence at autopsy compared with that in Hiroshima and Nagasaki, Japan. Cancer (1974) 1.07
Symptomatic versus asymptomatic papillary thyroid microcarcinoma: a retrospective analysis of surgical outcome and prognostic factors. Endocr J (1999) 1.06
Prognostic factors associated with the survival of patients developing loco-regional recurrences of differentiated thyroid carcinomas. J Clin Endocrinol Metab (2004) 1.05
Prospective outcomes of selective lymph node dissection for papillary thyroid carcinoma based on preoperative ultrasonography. World J Surg (2008) 1.02
BRAF V600E mutation and p27 kip1 expression in papillary carcinomas of the thyroid <or=1 cm and their paired lymph node metastases. Cancer (2007) 0.98
Occult well differentiated thyroid carcinoma presenting as cervical node disease. World J Surg (1995) 0.94
Clinicopathologic and immunohistochemical studies of papillary thyroid microcarcinoma presenting with cervical lymphadenopathy. World J Surg (1998) 0.93
Hyperthyroidism and thyroid cancer. Arch Pathol (1966) 0.93
Ill-defined edge on ultrasonographic examination can be a marker of aggressive characteristic of papillary thyroid microcarcinoma. World J Surg (2005) 0.90
Presidential address: beyond risk groups--a new look at differentiated thyroid cancer. Surgery (1998) 0.88
Not all "occult" papillary carcinomas are "minimal". Surgery (1988) 0.88
Management of low-risk papillary thyroid carcinoma: unique conventional policy in Japan and our efforts to improve the level of evidence. Surg Today (2010) 0.83
Is the management of thyroid nodules and differentiated thyroid cancer in accordance with recent consensus guidelines? - Results of a national survey. Clin Endocrinol (Oxf) (2007) 0.81
Papillary carcinoma of the thyroid gland. Sizes of 525 tumors found at autopsy in Hiroshima and Nagasaki. Cancer (1970) 0.78
[Clinicopathological studies of latent carcinoma of thyroid]. Nihon Naibunpi Gakkai Zasshi (1969) 0.75
[Incidental thyroid microcarcinoma in benign thyroid disease. Incidence in a total of 100 consecutive thyroidectomies]. Chir Ital (2006) 0.75
A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery (2004) 2.73
Prognostic factors and the therapeutic strategy for patients with bone metastasis from differentiated thyroid carcinoma. Surgery (2010) 1.92
Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate toll-like receptors. BMC Genomics (2007) 1.80
Treatment strategy for rectal carcinoids: a clinicopathological analysis of 229 cases at a single cancer institution. J Gastroenterol Hepatol (2012) 1.71
Feasibility and safety of granulocyte colony-stimulating factor treatment in patients with acute myocardial infarction. Int J Cardiol (2006) 1.52
Prospective application of our novel prognostic index in the treatment of anaplastic thyroid carcinoma. Surgery (2011) 1.51
Indications for gastrectomy after incomplete EMR for early gastric cancer. Gastric Cancer (2005) 1.45
Distinct diagnostic criteria for ultrasonographic examination of papillary thyroid carcinoma: a multicenter study. Thyroid (2005) 1.36
Alternative splicing of the human diacylglycerol kinase delta gene generates two isoforms differing in their expression patterns and in regulatory functions. J Biol Chem (2002) 1.19
Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer. Cancer Sci (2014) 1.19
From the Cover: Indispensability of the glutamate transporters GLAST and GLT1 to brain development. Proc Natl Acad Sci U S A (2006) 1.13
Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis. Rheumatology (Oxford) (2010) 1.13
Zoledronic acid in the treatment of bone metastases from differentiated thyroid carcinoma. Thyroid (2010) 1.10
Papillary thyroid carcinoma with distant metastases: survival predictors and the importance of local control. Surgery (2007) 1.09
Activation of peroxisome proliferator-activated receptor delta inhibits streptozotocin-induced diabetic nephropathy through anti-inflammatory mechanisms in mice. Diabetes (2011) 1.07
Bone anabolic effects of S-40503, a novel nonsteroidal selective androgen receptor modulator (SARM), in rat models of osteoporosis. Biol Pharm Bull (2003) 1.05
Diacylglycerol kinases: emerging downstream regulators in cell signaling systems. J Biochem (2002) 1.05
Lymph node metastasis from undifferentiated-type mucosal gastric cancer satisfying the expanded criteria for endoscopic resection based on routine histological examination. Gastric Cancer (2010) 1.04
In vitro activities of ME1036 (CP5609), a novel parenteral carbapenem, against methicillin-resistant staphylococci. Antimicrob Agents Chemother (2004) 1.03
Prospective outcomes of selective lymph node dissection for papillary thyroid carcinoma based on preoperative ultrasonography. World J Surg (2008) 1.02
Clinicopathology of pancreaticobiliary maljunction: relationship between alterations in background biliary epithelium and neoplastic development. J Hepatobiliary Pancreat Surg (2005) 1.02
Diacylglycerol kinase alpha suppresses tumor necrosis factor-alpha-induced apoptosis of human melanoma cells through NF-kappaB activation. Biochim Biophys Acta (2007) 1.01
Multicenter study evaluating the clinical performance of the OSNA assay for the molecular detection of lymph node metastases in gastric cancer patients. Gastric Cancer (2013) 0.99
OSNA-based novel molecular testing for lymph node metastases in colorectal cancer patients: results from a multicenter clinical performance study in Japan. Ann Surg Oncol (2011) 0.98
Image-diagnostic features of mature cystic teratomas of the pancreas: report on two cases difficult to diagnose preoperatively. J Hepatobiliary Pancreat Surg (2005) 0.98
Irinotecan plus cisplatin for therapy of small-cell carcinoma of the esophagus: report of 12 cases from single institution experience. Jpn J Clin Oncol (2008) 0.97
Phylogenetic analysis of Bacillus cereus isolates from severe systemic infections using multilocus sequence typing scheme. Microbiol Immunol (2006) 0.97
Does postoperative thyrotropin suppression therapy truly decrease recurrence in papillary thyroid carcinoma? A randomized controlled trial. J Clin Endocrinol Metab (2010) 0.95
Gastric parietal cells: potent endocrine role in secreting estrogen as a possible regulator of gastro-hepatic axis. Endocrinology (2002) 0.95
Endocrine carcinoma of the stomach: clinicopathological analysis of 27 surgically treated cases in a single institute. Gastric Cancer (2012) 0.95
Association between the functional polymorphism (C3435T) of the gene encoding P-glycoprotein (ABCB1) and major depressive disorder in the Japanese population. J Psychiatr Res (2012) 0.94
Therapeutic outcomes of endoscopic submucosal dissection of undifferentiated-type intramucosal gastric cancer without ulceration and preoperatively diagnosed as 20 millimetres or less in diameter. Dig Endosc (2010) 0.94
A new phylogenetic cluster of cereulide-producing Bacillus cereus strains. J Clin Microbiol (2007) 0.92
Growth phase-dependent effect of clindamycin on production of exoproteins by Streptococcus pyogenes. Antimicrob Agents Chemother (2006) 0.92
Cellular localization of the diazepam binding inhibitor in glial cells with special reference to its coexistence with brain-type fatty acid binding protein. Arch Histol Cytol (2002) 0.92
Malignant mucosal melanoma of the eustachian tube. Radiat Med (2008) 0.91
Clinical characterization of gastric lesions initially diagnosed as low-grade adenomas on forceps biopsy. Dig Endosc (2012) 0.91
Predictors of the efficacy of FOLFIRI plus bevacizumab as second-line treatment in metastatic colorectal cancer patients. Surg Today (2011) 0.90
Real-time monitoring of continuous-wave terahertz radiation using a fiber-based, terahertz-comb-referenced spectrum analyzer. Opt Express (2009) 0.90
Comparison of HER2 status between surgically resected specimens and matched biopsy specimens of gastric intestinal-type adenocarcinoma. Virchows Arch (2014) 0.90
A new microarray system to detect Streptococcus pneumoniae serotypes. J Biomed Biotechnol (2011) 0.90
Loss of hrs in the central nervous system causes accumulation of ubiquitinated proteins and neurodegeneration. Am J Pathol (2008) 0.89
Mucinous cystadenocarcinoma of the breast: a case report and review of the literature. Arch Pathol Lab Med (2003) 0.89
Growth factors stimulate expression of neuronal and glial miR-132. Neurosci Lett (2011) 0.88
Diacylglycerol kinase gamma serves as an upstream suppressor of Rac1 and lamellipodium formation. J Biol Chem (2004) 0.87
Effect of postoperative thyrotropin suppressive therapy on bone mineral density in patients with papillary thyroid carcinoma: a prospective controlled study. Surgery (2011) 0.87
Effects of the CACNA1C risk allele on neurocognition in patients with schizophrenia and healthy individuals. Sci Rep (2012) 0.87
A novel chemo-radiotherapy with low-dose daily cisplatin, 5-fluorouracil and doxorubicin for anaplastic thyroid carcinoma: a preliminary report. Jpn J Clin Oncol (2011) 0.87
Association between serum thyrotropin concentration and growth of asymptomatic papillary thyroid microcarcinoma. World J Surg (2014) 0.87
Identification of single nucleotide polymorphisms regulating peripheral blood mRNA expression with genome-wide significance: an eQTL study in the Japanese population. PLoS One (2013) 0.86
Encephalopathy, disseminated intravascular coagulation, and hemolytic-uremic syndrome after infection with enterohemorrhagic Escherichia coli O111. J Infect Chemother (2011) 0.86
Analyses of non-leucine-rich repeat (non-LRR) regions intervening between LRRs in proteins. Biochim Biophys Acta (2009) 0.86
Possible association of the semaphorin 3D gene (SEMA3D) with schizophrenia. J Psychiatr Res (2010) 0.86
An outbreak of measles virus infection due to a genotype D9 at a junior high school in Yamagata, Japan in 2004. Jpn J Infect Dis (2005) 0.86
Effect of pioglitazone on endothelial dysfunction after sirolimus-eluting stent implantation. Am J Cardiol (2011) 0.85
Invasive infection caused by carbapenem-resistant Acinetobacter soli, Japan. Emerg Infect Dis (2014) 0.85
A novel definition of extrathyroidal invasion for patients with papillary thyroid carcinoma for predicting prognosis. World J Surg (2012) 0.85
Twenty-two metachronous multiple signet-ring cell carcinomas treated with repeated gastrectomies and repeated endoscopic mucosal resections: report of a case. Surg Today (2009) 0.85
Variations in amount of TSST-1 produced by clinical methicillin resistant Staphylococcus aureus (MRSA) isolates and allelic variation in accessory gene regulator (agr) locus. BMC Microbiol (2009) 0.84
Endoscopic classification of intraductal lesions and histological diagnosis. Breast Cancer (2002) 0.84
Detection of invasive protein profile of Streptococcus pyogenes M1 isolates from pharyngitis patients. APMIS (2010) 0.84
Management of low-risk papillary thyroid carcinoma: unique conventional policy in Japan and our efforts to improve the level of evidence. Surg Today (2010) 0.83
The anti-fatigue effects of the low-molecular-weight fraction of bonito extract in mice. Biol Pharm Bull (2009) 0.83
Sonographic findings in three cases of carcinoma showing thymus-like differentiation. J Clin Ultrasound (2012) 0.83
Daily low-dose cisplatin-based concurrent chemoradiotherapy in patients with uterine cervical cancer with emphasis on elderly patients: a phase 2 trial. Int J Gynecol Cancer (2013) 0.82
Expansion of indications for endoscopic treatment of undifferentiated mucosal gastric cancer: analysis of intramucosal spread in resected specimens. Dig Dis Sci (2009) 0.82
Mechanism of edge restenosis after sirolimus-eluting stent implantation. J Invasive Cardiol (2012) 0.82
Frozen section is superior to imprint cytology for the intra-operative assessment of sentinel lymph node metastasis in stage I breast cancer patients. World J Surg Oncol (2006) 0.82
Intracoronary Acetylcholine Provocation Testing - Omission of the 20-µg Dose Is Feasible in Patients Without Coronary Artery Spasm in the Other Coronary Artery. Circ J (2016) 0.82
Incidence and prognostic value of lymph node metastasis on c-Kit-positive gastrointestinal stromal tumors of the stomach. Hepatogastroenterology (2011) 0.81
Muco-epidermoid carcinoma of the breast. Pathol Int (2006) 0.81
Re-evaluation of histopathological factors affecting prognosis of differentiated thyroid carcinoma in an iodine-sufficient country. World J Surg (2010) 0.81
Can narrow-band imaging be used to determine the surgical margin of superficial hypopharyngeal cancer? Acta Med Okayama (2008) 0.81
Chemotherapy for anaplastic thyroid cancer using docetaxel and cisplatin: report of eight cases. Surg Today (2015) 0.81
Re-restenosis and target lesion revascularization after treatment of sirolimus-eluting stent restenosis: retrospective analysis of 4 Japanese hospitals. Circ J (2009) 0.80
Mechanism of the tissue-specific action of the selective androgen receptor modulator S-101479. Biol Pharm Bull (2013) 0.80
Colonic Marking With Near-Infrared, Light-Emitting, Diode-Activated Indocyanine Green for Laparoscopic Colorectal Surgery. Dis Colon Rectum (2016) 0.80
Expression of Ca²⁺-dependent activator protein for secretion 2 is increased in the brains of schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry (2011) 0.80
Anti-androgenic effects of S-40542, a novel non-steroidal selective androgen receptor modulator (SARM) for the treatment of benign prostatic hyperplasia. Prostate (2012) 0.80
Support for association between the Ser205Leu polymorphism of p75(NTR) and major depressive disorder. J Hum Genet (2011) 0.80
Purification, characterization, and overexpression of psychrophilic and thermolabile malate dehydrogenase of a novel antarctic psychrotolerant, Flavobacterium frigidimaris KUC-1. Biosci Biotechnol Biochem (2005) 0.80
Metastatic thyroid tumors: ultrasonographic features, prognostic factors and outcomes in 29 cases. Surg Today (2013) 0.79
Outcomes of lymphadenectomy for lymph node recurrence after esophagectomy or definitive chemoradiotherapy for squamous cell carcinoma of the esophagus. Gen Thorac Cardiovasc Surg (2014) 0.79